NasoVac (influenza vaccine) / Serum Institute of India - LARVOL DELTA

Human health implications of emerging diseases and the current situation in India's vaccine industry. (PubMed, Sci One Health) - "With heavy privatesector investments, Indian pharmacology now provides core Expanded Programme on Immunization vaccines to United Nations International Children's Emergency Fund, producing previously unattainable vaccines for diseases like meningitis, hepatitis B, pneumococcal conjugate, rotavirus, influenza A (H1N1), and COVID-19...The Serum Institute has developed several vaccines, including Nasovac, MenAfriVac, Pentavac, and an inactivated polio vaccine...Despite its booming economy and technical advances, India's disproportionate share of the world's child mortality rate remains unchanged. However, the growing production and distribution of vaccinations in developing nations has initiated a new era, leading to a worldwide decline in childhood death and disease."

Journal • Review • CNS Disorders • Hepatitis B • Hepatology • Infectious Disease • Inflammation • Influenza • Measles • Novel Coronavirus Disease • Pertussis • Pneumococcal Infections • Respiratory Diseases • Rotavirus Infections • Tetanus

NASIMMUNE: A Study of Intranasal Live Attenuated Influenza Vaccine Immunogenicity and Associations With the Nasopharyngeal Microbiome Among Children in the Gambia (clinicaltrials.gov) - P4; N=365; Not yet recruiting; Sponsor: Medical Research Council Unit, The Gambia

New P4 trial • Biosimilar • Immunology

NASIMMUNE: A Study of Intranasal Live Attenuated Influenza Vaccine Immunogenicity and Associations With the Nasopharyngeal Microbiome Among Children in the Gambia (clinicaltrials.gov) - P4; N=364; Completed; Sponsor: London School of Hygiene and Tropical Medicine; Active, not recruiting ➔ Completed

Trial completion

NASIMMUNE: A Study of Intranasal Live Attenuated Influenza Vaccine Immunogenicity and Associations With the Nasopharyngeal Microbiome Among Children in the Gambia (clinicaltrials.gov) - P4; N=365; Active, not recruiting; Sponsor: London School of Hygiene and Tropical Medicine; Recruiting ➔ Active, not recruiting

Clinical • Enrollment closed